These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 12512149

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Endocrine treatment of prostate cancer.
    Tammela T.
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intermittent androgen deprivation therapy may prolong the duration of androgen dependence of well-differentiated prostate cancer.
    Kaneko Y, Maekawa S, Arakaki R, Okada Y, Terada N, Nishimura K.
    Hinyokika Kiyo; 2006 Apr; 52(4):259-64. PubMed ID: 16686352
    [Abstract] [Full Text] [Related]

  • 9. Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.
    Koutsilieris M, Dimopoulos T, Milathianakis C, Bogdanos J, Karamanolakis D, Pissimissis N, Halapas A, Lembessis P, Papaioannou A, Sourla A.
    BJU Int; 2007 Jul; 100 Suppl 2():60-2. PubMed ID: 17594363
    [No Abstract] [Full Text] [Related]

  • 10. [Laminectomy in metastasizing prostatic neoplasms with spinal cord compression].
    Brand HP, Kreutz G, Brüderl RH.
    Helv Chir Acta; 1978 Jul; 45(3):293-6. PubMed ID: 701065
    [No Abstract] [Full Text] [Related]

  • 11. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.
    Calais da Silva FE, Bono AV, Whelan P, Brausi M, Marques Queimadelos A, Martin JA, Kirkali Z, Calais da Silva FM, Robertson C.
    Eur Urol; 2009 Jun; 55(6):1269-77. PubMed ID: 19249153
    [Abstract] [Full Text] [Related]

  • 12. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T, Nutahara K, Higashihara E.
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [Abstract] [Full Text] [Related]

  • 13. Prostate cancer: the role of hormonal therapy.
    Salesi N, Carlini P, Ruggeri EM, Ferretti G, Bria E, Cognetti F.
    J Exp Clin Cancer Res; 2005 Jun; 24(2):175-80. PubMed ID: 16110748
    [Abstract] [Full Text] [Related]

  • 14. Posterolateral spinal cord decompression in patients with metastasis: an endoscopic assisted approach.
    St Clair SF, McLain RF.
    Surg Technol Int; 2006 Jun; 15():257-63. PubMed ID: 17029184
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications.
    Krupski TL, Foley KA, Baser O, Long S, Macarios D, Litwin MS.
    J Urol; 2007 Oct; 178(4 Pt 1):1423-8. PubMed ID: 17706711
    [Abstract] [Full Text] [Related]

  • 17. Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancer.
    Chen YJ, Chang GC, Chen HT, Yang TY, Kuo BI, Hsu HC, Yang HW, Lee TS.
    Spine (Phila Pa 1976); 2007 Jul 01; 32(15):E413-8. PubMed ID: 17621197
    [Abstract] [Full Text] [Related]

  • 18. Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation.
    Salonen AJ, Viitanen J, Lundstedt S, Ala-Opas M, Taari K, Tammela TL, FinnProstate Group.
    J Urol; 2008 Sep 01; 180(3):915-9; discussion 919-20. PubMed ID: 18635219
    [Abstract] [Full Text] [Related]

  • 19. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a Japanese perspective--the effect of primary androgen deprivation therapy on stage C prostate cancer.
    Akaza H.
    BJU Int; 2007 Jan 01; 99 Suppl 1():10-2; discussion 17-8. PubMed ID: 17229161
    [Abstract] [Full Text] [Related]

  • 20. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
    Daskivich TJ, Oh WK.
    Urology; 2006 May 01; 67(5):1084.e15-7. PubMed ID: 16698377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.